Fundraising Fox
ImmunoBiome
2 known investors
Find your way into ImmunoBiome
Sign up to see every warm intro you have to ImmunoBiome
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ImmunoBiome team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ImmunoBiome develops microbiome-based therapeutics targeting intractable immune diseases such as cancer and autoimmune disorders, drawing on immunology, bioinformatics, and microbiome research. The company operates in the biotech and drug development space.
Investors · 2
Frequently asked questions
- What does ImmunoBiome do?
- ImmunoBiome develops microbiome-based therapeutics targeting intractable immune diseases such as cancer and autoimmune disorders, drawing on immunology, bioinformatics, and microbiome research. The company operates in the biotech and drug development space.
- Who are ImmunoBiome's investors?
- ImmunoBiome's investors include Aju IB Investment, SBI Investment Korea Co. Ltd..